Raptiva Lawsuits Cause of Controversy
Plaque Psoriasis Symptoms in the News
Raptiva Lawsuits Cause of Controversy
Filed under: plaque psoriasis symptoms
According to the FDA, the patients were between the ages of 47 and 73 and were using Raptiva to treat moderate to severe plaque psoriasis. Two of the patients with confirmed PML died and one patient with possible PML also died. One patient with …
Source
Biocon gets approval to sell psoriasis drug in India
Filed under: plaque psoriasis symptoms
Itolizumab is a therapy to treat persistent plaque psorisis, and it is the second biologic — a drug that works by implementing a biological process in the body — developed at the company's headquarters in Bangalore, according to the Business Standard.
Source
Celgene Upbeat About 2013
Filed under: plaque psoriasis symptoms
Recently, Celgene presented encouraging data from two phase III studies (ESTEEM 1 and 2), evaluating apremilast in patients suffering from moderate-to-severe chronic plaque psoriasis. Celgene expects to seek FDA approval for the indication on the basis …
Source
More Plaque Psoriasis Symptoms Information…